UniProt ID | PRR14_HUMAN | |
---|---|---|
UniProt AC | Q9BWN1 | |
Protein Name | Proline-rich protein 14 | |
Gene Name | PRR14 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 585 | |
Subcellular Localization | Chromosome . Nucleus . Nucleus lamina . Nucleus, nucleoplasm . During interphase, associated with peripheral heterochromatin at the nuclear lamina. Released from the nuclear lamina in mitotic prophase and remains highly dispersed in metaphase. Associ | |
Protein Description | Functions in tethering peripheral heterochromatin to the nuclear lamina during interphase, possibly through the interaction with heterochromatin protein CBX5/HP1 alpha. [PubMed: 24209742 Might play a role in reattaching heterochromatin to the nuclear lamina at mitotic exit] | |
Protein Sequence | MDLPGDSSPPGQPRLCRQPLTRALWGARSPKRPRLQLPGAPSPLEKASRRVLAVVLEDVMAVHMVPVVPSKQTSIPQHHSYHQDPVHRQPPASPPRQAGWSSQARPPDPLCLCREPLSRIHRTSSTLRRRSRTTPGPEEGPSQKVDRAPQPTLVVMLEDIASPRPPAEGFIDETPNFIIPAQRAEPMRIVRQPTPPPGDLEPPFQPSALPADPLESPPTAPDPALELPSTPPPSSLLRPRLSPWGLAPLFRSVRSKLESFADIFLTPNKTPQPPPPSPPMKLELKIAISEAEQSGAAEGTASVSPRPPIRQWRTQDHNTPALLPKPSLGRSYSCPDLGPPGPGTCTWPPAPPQPSRPRPRRHTVGGGEMARAPPPPRPCLRKEVFPLGGVGASPSLTTSCSSTASTSFSEPAEPRLGSTKGKEPRASKDQVLSEPETKTMGKVSRFRIRRTPARPQLNLTPMGLPRPIRLNKKEFSLEEIYTNKNYQSPTTRRTFETIFEEPRERNGTLIFTSSRKLRRAVEFRDSSLPRSRRPSRGVRAAGGRTVPPNVAPSPDVGPLLQQRLEELDALLLEEETVDREQPHWT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDLPGDSS -------CCCCCCCC | 12.31 | 22814378 | |
7 | Phosphorylation | -MDLPGDSSPPGQPR -CCCCCCCCCCCCCC | 51.14 | 22199227 | |
8 | Phosphorylation | MDLPGDSSPPGQPRL CCCCCCCCCCCCCCC | 39.59 | 22199227 | |
29 | Phosphorylation | RALWGARSPKRPRLQ HHHHCCCCCCCCCCC | 33.95 | 27422710 | |
42 | Phosphorylation | LQLPGAPSPLEKASR CCCCCCCCHHHHHHH | 41.40 | 29255136 | |
93 | Phosphorylation | VHRQPPASPPRQAGW CCCCCCCCCCCCCCC | 41.01 | 26657352 | |
131 | Phosphorylation | SSTLRRRSRTTPGPE HHHHHHHCCCCCCCC | 31.97 | 24719451 | |
133 | Phosphorylation | TLRRRSRTTPGPEEG HHHHHCCCCCCCCCC | 38.29 | 22985185 | |
134 | Phosphorylation | LRRRSRTTPGPEEGP HHHHCCCCCCCCCCC | 25.74 | 27794612 | |
162 | Phosphorylation | VMLEDIASPRPPAEG EEEHHCCCCCCCCCC | 23.06 | 25159151 | |
194 | Phosphorylation | MRIVRQPTPPPGDLE CEEEECCCCCCCCCC | 39.84 | 27251275 | |
229 | Phosphorylation | DPALELPSTPPPSSL CCCCCCCCCCCCHHH | 67.19 | 21552520 | |
230 | Phosphorylation | PALELPSTPPPSSLL CCCCCCCCCCCHHHC | 37.56 | 24275569 | |
235 | Phosphorylation | PSTPPPSSLLRPRLS CCCCCCHHHCCCCCC | 36.88 | 24719451 | |
242 | Phosphorylation | SLLRPRLSPWGLAPL HHCCCCCCHHCHHHH | 21.64 | 25106551 | |
256 | Ubiquitination | LFRSVRSKLESFADI HHHHHHHHHHHHHHE | 45.79 | 21890473 | |
259 | Phosphorylation | SVRSKLESFADIFLT HHHHHHHHHHHEECC | 35.85 | 28978645 | |
266 | Phosphorylation | SFADIFLTPNKTPQP HHHHEECCCCCCCCC | 17.67 | 21815630 | |
270 | Phosphorylation | IFLTPNKTPQPPPPS EECCCCCCCCCCCCC | 33.52 | 23186163 | |
277 | Phosphorylation | TPQPPPPSPPMKLEL CCCCCCCCCCCEEEE | 47.62 | 29255136 | |
294 | Phosphorylation | AISEAEQSGAAEGTA EEEHHHHCCCCCCCC | 23.16 | 24719451 | |
300 | Phosphorylation | QSGAAEGTASVSPRP HCCCCCCCCCCCCCC | 13.78 | 30624053 | |
302 | Phosphorylation | GAAEGTASVSPRPPI CCCCCCCCCCCCCCC | 23.98 | 30624053 | |
304 | Phosphorylation | AEGTASVSPRPPIRQ CCCCCCCCCCCCCCC | 16.82 | 27050516 | |
314 | Phosphorylation | PPIRQWRTQDHNTPA CCCCCCCCCCCCCCC | 35.08 | 27732954 | |
319 | Phosphorylation | WRTQDHNTPALLPKP CCCCCCCCCCCCCCC | 13.40 | 27732954 | |
331 | Phosphorylation | PKPSLGRSYSCPDLG CCCCCCCCCCCCCCC | 21.43 | 24719451 | |
332 | Phosphorylation | KPSLGRSYSCPDLGP CCCCCCCCCCCCCCC | 16.97 | 28152594 | |
333 | Phosphorylation | PSLGRSYSCPDLGPP CCCCCCCCCCCCCCC | 22.03 | 28152594 | |
363 | Phosphorylation | RPRPRRHTVGGGEMA CCCCCCCCCCCCHHC | 21.02 | 26657352 | |
418 | Phosphorylation | PAEPRLGSTKGKEPR CCCCCCCCCCCCCCC | 31.38 | 22210691 | |
419 | Phosphorylation | AEPRLGSTKGKEPRA CCCCCCCCCCCCCCC | 41.85 | 22210691 | |
427 | Phosphorylation | KGKEPRASKDQVLSE CCCCCCCCHHHCCCC | 37.74 | 29457462 | |
433 | Phosphorylation | ASKDQVLSEPETKTM CCHHHCCCCCCCCCC | 52.85 | 25159151 | |
451 | Phosphorylation | SRFRIRRTPARPQLN EEEEEECCCCCCCCC | 16.08 | 28555341 | |
460 | Phosphorylation | ARPQLNLTPMGLPRP CCCCCCCCCCCCCCC | 15.34 | 28555341 | |
476 | Phosphorylation | RLNKKEFSLEEIYTN CCCCCEECHHHHHCC | 35.64 | - | |
481 | Phosphorylation | EFSLEEIYTNKNYQS EECHHHHHCCCCCCC | 13.93 | - | |
488 | Phosphorylation | YTNKNYQSPTTRRTF HCCCCCCCCCCHHHH | 17.54 | 25262027 | |
490 | Phosphorylation | NKNYQSPTTRRTFET CCCCCCCCCHHHHHH | 37.88 | 25262027 | |
491 | Phosphorylation | KNYQSPTTRRTFETI CCCCCCCCHHHHHHH | 22.87 | 25262027 | |
508 | Phosphorylation | EPRERNGTLIFTSSR CHHHHCCEEEECCCH | 21.89 | 23663014 | |
512 | Phosphorylation | RNGTLIFTSSRKLRR HCCEEEECCCHHHHH | 20.85 | 23663014 | |
513 | Phosphorylation | NGTLIFTSSRKLRRA CCEEEECCCHHHHHH | 19.86 | 23663014 | |
514 | Phosphorylation | GTLIFTSSRKLRRAV CEEEECCCHHHHHHH | 30.31 | 23663014 | |
526 | Phosphorylation | RAVEFRDSSLPRSRR HHHHHCCCCCCCCCC | 29.53 | 23898821 | |
527 | Phosphorylation | AVEFRDSSLPRSRRP HHHHCCCCCCCCCCC | 46.83 | 23898821 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PRR14_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRR14_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRR14_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
MA2B2_HUMAN | MAN2B2 | physical | 28514442 | |
2A5D_HUMAN | PPP2R5D | physical | 28514442 | |
2A5A_HUMAN | PPP2R5A | physical | 28514442 | |
2A5E_HUMAN | PPP2R5E | physical | 28514442 | |
2A5G_HUMAN | PPP2R5C | physical | 28514442 | |
CBX5_HUMAN | CBX5 | physical | 28514442 | |
2AAB_HUMAN | PPP2R1B | physical | 28514442 | |
PP2AA_HUMAN | PPP2CA | physical | 28514442 | |
2AAA_HUMAN | PPP2R1A | physical | 28514442 | |
CBX1_HUMAN | CBX1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277, AND MASSSPECTROMETRY. |